Research

Showing   of 205 results

Thumbnail image of UH Rainbow Babies and Children's Hospital.

University Hospitals Enrolls First Pediatric Patient in International Research Study

Led by Princess Ogbogu, MD, the study will evaluate benralizumab in children with hypereosinophilic syndrome

Cleveland Researchers Discover Potential New Treatment for Parkinson’s Disease and Other Neurodegenerative Conditions

New study from University Hospitals, Case Western Reserve University and the Cleveland VA published in Redox Biology.

Cleveland Research Team Identifies Key Driver of Age-Related Cognitive Decline

Researchers from University Hospitals, Case Western Reserve University and the Cleveland VA published preclinical results in Proceedings of the National Academy of Sciences (PNAS).

Physician researcher from UH Rainbow Babies & Children’s co-authors two studies published in the New England Journal of Medicine

Results from the studies are encouraging for investigational gene therapies in sickle cell disease.

Thumbnail image of the Cleveland skyline with logos of  UH, Case, and Creative Destruction Labs.

Creative Destruction Lab Launches CDL-Cleveland in Partnership with University Hospitals and Case Western Reserve University

CDL-Cleveland will host a new Healthcare Delivery stream — the first CDL Site anchored to a health system — giving science-based ventures direct access to a clinical environment where their technologies can be tested, validated and adopted.

Thumbnail image of scientist Seth Field.

Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers

New study of human cancers published in Science Signaling.

Harrington Discovery Institute Announces 2026 Scholar-Innovator Award Recipients

Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.

Dee and Jimmy Haslam

Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals

Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.

Results are loading...